Cutler Group LP Emergent Bio Solutions Inc. Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$20.09 - $35.8 $20,732 - $36,945	-1,032 Reduced 83.56%	203 $4,000
Q2 2022 Aug 04, 2022	BUY	$27.42 - $43.63 $14,669 - $23,342	535 Added 76.43%	1,235 $38,000
Q1 2022 Apr 14, 2022	BUY	$36.48 - $52.22 $18,240 - $26,110	500 Added 250.0%	700 $28,000
Q4 2021 Jan 18, 2022	BUY	$33.11 - $55.01 $6,622 - $11,002	200 New	200 $8,000
Q3 2021 Oct 26, 2021	SELL	$50.07 - $66.05 $25,035 - $33,025	-500 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$56.61 - $80.46 $5,661 - $8,045	100 Added 25.0%	500 $31,000
Q1 2021 Apr 26, 2021	SELL	$86.23 - $125.19 $61,223 - $88,884	-710 Reduced 63.96%	400 $37,000
Q4 2020 Jan 21, 2021	BUY	$79.17 - $111.47 $56,210 - $79,143	710 Added 177.5%	1,110 $99,000
Q3 2020 Oct 27, 2020	BUY	$81.91 - $134.94 $32,764 - $53,976	400 New	400 $41,000

162

33.2M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $499M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.